Ms Shelley Baird
Project Manager - CBD Studies
Centre for Youth Mental Health (Orygen)
11 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for Psychosis
DOI: 10.1111/eip.701832025
Journal article
Characteristics of Youth With Recent Substance Use With and Without Substance Use Disorder Presenting for Primary Mental Healthcare in Australia: Baseline Findings From the INTEGRATE Trial
DOI: 10.1111/eip.701062025
Journal article
Perceived stigma and self-stigma in young people at ultra-high risk for psychosis: Associations with identity-related, psychological and functional outcomes
DOI: 10.1016/j.schres.2025.08.0132025
Journal article
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
DOI: 10.1093/schbul/sbae1492024
Journal article
Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosis
DOI: 10.1016/j.psychres.2024.1159662023
Journal article
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized Trial
DOI: 10.1001/jamapsychiatry.2023.19472020
Journal article
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): A randomised clinical trial of rosuvastatin and aspirin
DOI: 10.1186/s12916-019-1475-6
RECENT SCHOLARLY WORKS
2019
Conference Proceedings
Youth depression alleviation with anti-inflammatory agents (YoDA-A): A placebo-controlled randomised augmentation trial of rosuvastatin and aspirin
2019
Conference Proceedings
The addition of fluoxetine to cognitive behavioural therapy for youth depression: The YoDA-C randomised clinical trial
2018
Journal article
Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin
DOI: 10.1111/eip.12280